Johnson & Johnson (JNJ) Short term Debt (2009 - 2026)

Johnson & Johnson (JNJ) posted Short term Debt of $17.5 billion for Q1 2026, up 105.53% sequentially from $8.5 billion in Q4 2025, and up 25.64% YoY from $13.9 billion in Q1 2025.

Johnson & Johnson (JNJ) Short term Debt (2009 - 2026) Analysis & Trends

Johnson & Johnson (JNJ) has 18 years of Short term Debt data on file, last reported at $17.5 billion in Q1 2026.

  • Quarterly Short term Debt rose 25.64% year-over-year to $17.5 billion in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $17.5 billion (up 25.64% YoY) and the FY2025 annual result came in at $8.5 billion, up 41.99% from the prior year.
  • Short term Debt grew to $17.5 billion in Q1 2026 per JNJ's latest filing, from $8.5 billion in the prior quarter.
  • The five-year high for Short term Debt was $18.0 billion in Q2 2023, with the low at $3.5 billion in Q4 2023.
  • Average Short term Debt over 5 years is $8.5 billion, with a median of $7.4 billion recorded in 2025.
  • The widest YoY moves for Short term Debt: up 318.41% in 2023, down 72.95% in 2023.
  • Johnson & Johnson's Short term Debt stood at $4.4 billion in 2022, then dropped by 21.99% to $3.5 billion in 2023, then surged by 73.37% to $6.0 billion in 2024, then jumped by 41.99% to $8.5 billion in 2025, then jumped by 105.53% to $17.5 billion in 2026.
  • Business Quant data shows JNJ's Short term Debt at $17.5 billion in Q1 2026, $8.5 billion in Q4 2025, and $6.4 billion in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,066.16 Bn 1,060.88 Bn 16.22 Bn
2 Johnson & Johnson 611.69 Bn 589.64 Bn 15.96 Bn
3 AbbVie 444.34 Bn 434.99 Bn 10.78 Bn
4 Astrazeneca 284.94 Bn 277.05 Bn 12.61 Bn
5 Merck 224.23 Bn 218.58 Bn 12.09 Bn
6 Amgen 195.12 Bn 183.08 Bn 5.87 Bn
7 Gilead Sciences 156.45 Bn 148.73 Bn 5.52 Bn
8 Pfizer 136.01 Bn 123.24 Bn -1.21 Bn
9 Novartis Ag 113.45 Bn 113.67 Bn -
10 Biogen 30.87 Bn 26.59 Bn 1.82 Bn

Historic Data

Download Data
DateValue
Mar 29, 2026 17.46 Bn
Dec 28, 2025 8.50 Bn
Sep 28, 2025 6.39 Bn
Jun 29, 2025 11.53 Bn
Mar 30, 2025 13.90 Bn
Dec 29, 2024 5.98 Bn
Sep 29, 2024 4.46 Bn
Jun 30, 2024 9.86 Bn
Mar 31, 2024 8.55 Bn
Dec 31, 2023 3.45 Bn
Oct 1, 2023 3.87 Bn
Jul 2, 2023 11.70 Bn
Apr 2, 2023 17.98 Bn
Jan 1, 2023 12.76 Bn
Oct 2, 2022 4.42 Bn
Jul 3, 2022 4.31 Bn
Apr 3, 2022 4.30 Bn
Jan 2, 2022 3.77 Bn
Oct 3, 2021 3.80 Bn
Jul 4, 2021 3.17 Bn